Cell Counting Market Is Predicted To Grow Swiftly Due To Growing Government Initiatives Working To Promote Development Of Cell Therapeutics Till 2025: Grand View Research, Inc.
The global cell counting market is expected to reach USD 1.7
billion by 2025, according to a new report by Grand View Research, Inc.
Government initiatives working to promote development of cell therapeutics,
wherein cell counting plays an imperative role, is expanding growth prospects
for the market. As a result of extensive R&D activities, the number of
diseases treated with the help of stem cells increased to 82 in 2016 from 27 in
2005. Also, California Institute for Regenerative Medicine’s funding of USD 271
million for stem cell therapy created 12 R&D facilities in California, and
these facilities brought approximately USD 543 million funding. In addition, it
is also funded by National Institutes of Health (NIH), which approximately
invested USD 1,429 million in 2015.
Increase in the number of
collaborations of research institutes with various public and private entities
to promote R&D has provided significant boost to the market. Growing number
of proposed guidelines and recommendations for public and private laboratories
to ensure high-quality standards and facilitate generation of accurate results
are likely to improve adoption of instruments over the coming years. For
instance, in May 2016, the International Society for Stem Cell Research updated
guidelines for the development of cell-based therapy and research. The proposed
guidelines focus on all stages of R&D and improve quality of preclinical
studies.
Browse full research
report on Cell Counting Market: http://www.grandviewresearch.com/industry-analysis/cell-counting-market
- Spectrophotometers
accounted forthe largest market share in 2016. This can be attributed to
high penetration in various applications such as toxicology studies,
bioprocessing, and others
- Automated
counters were anticipated to grow at an exponential rate during the
forecast period. Benefits such as short testing time, reduced error
occurrence, and interoperator variability are expected to further increase
demand for automated counters
- In the
end-use segment, research and academic institutes accounted for the
largest market share in 2016, owing to growing number of government
initiatives focused toward promoting R&D in various toxicology studies
- Research and
academic institutes are also expected to witness exponential growth
opportunities, owing to the growing adoption of instruments for optimum
drug concentration in therapeutics
- North America
held the largest share of the market, owing to increase in number of
supportive initiatives to fund R&D, which is anticipated to result in
higher adoption of automated instruments
- Asia Pacific
is anticipated to grow with a lucrative CAGR during the forecast period.
This lucrative growth rate is a consequence of improvements in testing
facilities
- Level of
competition is high as key players are adopting strategies such as new
product development and strategic collaborations & agreements to gain
competitive advantage
Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-cell-counting-market
About Grand View Research,
Inc:
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
For more information: http://www.grandviewresearch.com
Comments
Post a Comment